Literature DB >> 3343231

Peptidyl sulfonium salts. A new class of protease inhibitors.

E Shaw1.   

Abstract

The possibility has been examined that peptidylmethyl sulfonium salts might affinity label proteases by an alkyl transfer from sulfur to an active center residue. The synthesis of a number of agents of this type is described as well as initial results of their effect on cysteinyl proteases, papain and cathepsin B. These are readily inactivated by reagents in which the peptidyl portion contains features that promote binding to the proteases such as a penultimate phenylalanine residue. Irreversible inactivation ensues by transfer of the peptidyl portion, not methyl groups. Peptidylmethyl sulfonium salts lose a proton to form an ylide structure which may be the prevalent form at physiological pH values. The ylide may also be the active affinity labeling form of the reagent since the rate of inactivation of cathepsin B increases with pH. In contrast, the action of another affinity labeling reagent for cathepsin B, benzyloxycarbonyl-Phe-AlaCHN2, a diazomethyl ketone, is relatively independent of pH.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3343231

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  The inactivation of the cysteinyl exopeptidases cathepsin H and C by affinity-labelling reagents.

Authors:  H Angliker; P Wikstrom; H Kirschke; E Shaw
Journal:  Biochem J       Date:  1989-08-15       Impact factor: 3.857

2.  Peptidyl vinyl sulphones: a new class of potent and selective cysteine protease inhibitors: S2P2 specificity of human cathepsin O2 in comparison with cathepsins S and L.

Authors:  D Brömme; J L Klaus; K Okamoto; D Rasnick; J T Palmer
Journal:  Biochem J       Date:  1996-04-01       Impact factor: 3.857

Review 3.  Cathepsin B and its endogenous inhibitors: the role in tumor malignancy.

Authors:  B F Sloane; K Moin; E Krepela; J Rozhin
Journal:  Cancer Metastasis Rev       Date:  1990-12       Impact factor: 9.264

4.  Identification and optimization of a novel inhibitor of mitochondrial calpain 10.

Authors:  Kyle A Rasbach; David D Arrington; Sina Odejinmi; Chris Giguere; Craig C Beeson; Rick G Schnellmann
Journal:  J Med Chem       Date:  2009-01-08       Impact factor: 7.446

5.  The synthesis of inhibitors for processing proteinases and their action on the Kex2 proteinase of yeast.

Authors:  H Angliker; P Wikstrom; E Shaw; C Brenner; R S Fuller
Journal:  Biochem J       Date:  1993-07-01       Impact factor: 3.857

6.  Comparative behaviour of calpain and cathepsin B toward peptidyl acyloxymethyl ketones, sulphonium methyl ketones and other potential inhibitors of cysteine proteinases.

Authors:  D H Pliura; B J Bonaventura; R A Smith; P J Coles; A Krantz
Journal:  Biochem J       Date:  1992-12-15       Impact factor: 3.857

7.  The synthesis and properties of peptidylmethylsulphonium salts with two cationic residues as potential inhibitors of prohormone processing.

Authors:  A Zumbrunn; S Stone; E Shaw
Journal:  Biochem J       Date:  1988-12-15       Impact factor: 3.857

8.  The inhibition of proinsulin-processing endopeptidase activities by active-site-directed peptides.

Authors:  C J Rhodes; A Zumbrunn; E M Bailyes; E Shaw; J C Hutton
Journal:  Biochem J       Date:  1989-02-15       Impact factor: 3.857

9.  Application of a Sulfoxonium Ylide Electrophile to Generate Cathepsin X-Selective Activity-Based Probes.

Authors:  Simon J Mountford; Bethany M Anderson; Bangyan Xu; Elean S V Tay; Monika Szabo; My-Linh Hoang; Jiayin Diao; Luigi Aurelio; Rhiannon I Campden; Erik Lindström; Erica K Sloan; Robin M Yates; Nigel W Bunnett; Philip E Thompson; Laura E Edgington-Mitchell
Journal:  ACS Chem Biol       Date:  2020-02-14       Impact factor: 5.100

10.  Influenza virus hemagglutinin with multibasic cleavage site is activated by furin, a subtilisin-like endoprotease.

Authors:  A Stieneke-Gröber; M Vey; H Angliker; E Shaw; G Thomas; C Roberts; H D Klenk; W Garten
Journal:  EMBO J       Date:  1992-07       Impact factor: 11.598

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.